Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Sulfacetamide
Drug ID BADD_D02088
Description An anti-infective agent that is used topically to treat skin infections and orally for urinary tract infections.
Indications and Usage For the treatment of bacterial vaginitis, keratitis, acute conjunctivitis, and blepharitis.
Marketing Status approved
ATC Code D10AF06; S01AB04
DrugBank ID DB00634
KEGG ID D05947
MeSH ID D013409
PubChem ID 5320
TTD Drug ID D0M4VM
NDC Product Code 51927-1428; 17349-0002
UNII 4965G3J0F5
Synonyms Sulfacetamide | Acetylsulfanilamide | Sulphacetamide | Sodium Sulamyd | Sulamyd, Sodium | Colircusi Sulfacetamida | Sulfacetamida, Colircusi | Sulfacetamide Sodium | Sulfacetamide, Monosodium Salt, Anhydrous | Sulfacil | Sulfacyl | Sulfair | Acetopt | AK-Sulf | AK Sulf | Albucid | Antébor | Sulf-10 | Sulf 10 | Bleph | Ceta Sulfa | Cetamide | Coliriocilina Sulfacetam | Sulfacetam, Coliriocilina | Isopto Cetamide | Sulfacetamide Monosodium Salt | Belph-10 | Belph 10
Chemical Information
Molecular Formula C8H10N2O3S
CAS Registry Number 144-80-9
SMILES CC(=O)NS(=O)(=O)C1=CC=C(C=C1)N
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Agranulocytosis01.02.03.001---
Aplastic anaemia01.03.03.002---
Blister12.01.06.002; 23.03.01.001---
Conjunctival irritation06.04.01.007---
Death08.04.01.001--
Dermatitis bullous23.03.01.002--
Erythema23.03.06.001---
Erythema multiforme10.01.03.015; 23.03.01.003--
Hepatic necrosis09.01.07.002--
Hypersensitivity10.01.03.003--
Infection11.01.08.002---
Oedema08.01.07.006; 14.05.06.010---
Pain08.01.08.004--
Pruritus23.03.12.001--
Stevens-Johnson syndrome10.01.01.045; 11.07.01.005; 12.03.01.014; 23.03.01.007--
Systemic lupus erythematosus10.04.03.004; 15.06.02.003; 23.03.02.006---
Toxic epidermal necrolysis10.01.01.006; 11.07.01.006; 12.03.01.015; 23.03.01.008--
Conjunctival hyperaemia06.04.01.004---
Blood disorder01.05.01.004---
The 1th Page    1    Total 1 Pages
ADReCS-Target
Drug Name ADR Term Target
Tip:  Drug Name  ADR Term  Protein  Variation  Gene